Basic information
Biomarker: miR-151a-5
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Nanjing
Followed up time :
Subgroup 1 name : testing stage
Subgroup 1 number: 44
Subgroup 2 name: controls
Subgroup 2 number: 34
Cohort statistics: cutoff<50;cutoff>50
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 172 | endometrial cancer | 93 | healthy | 79 |
Sample information
Description: A signature consisting of 3 plasma miRNAs was identified and showed potential for the non-invasive diagnosis of EC.
Sample type : plasma
Sample method: qRT-PCR
Expression pattern : Ct-value < 37, 1.5-fold altered expression in EC patients compared with healthy controls
Expression elevation: The expression of miRNAs in plasma or exosomes was calculated using the 2−∆∆Ct method (cel-miR-39 as exogenous reference miRNA for plasma samples; RNU6B (U6) [U6] for tissue sample normalization; ∆Ct = Ct miRNA − Ct normalizer; Ct: the threshold cycle)
Disease information
Cohort age: 35;33
Subgroup 1 age: 14;30
Subgroup 2 age: 21;13
Related information
HGNC miRNA approved symbol: MIR151A
HGNC miRNA approved name: microRNA 151a
HGNC miRNA locus type: RNA, micro
HGNC miRNA symbol status: Approved
HGNC miRNA ID: HGNC:31762
HGNC miRNA link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:31762
Stem loop sequence symbol: hsa-mir-151a
Stem loop sequence accession: MI0000809
Stem loop sequence gene family: MIPF0000057
Stem loop sequence annotation confidence: not enough data
Mature sequence symbol: hsa-miR-151a-5p$hsa-miR-151a-3p
Mature sequence accession: MIMAT0004697$MIMAT0000757
Previous IDs: hsa-miR-151-5p$hsa-miR-151;hsa-miR-151-3p
Evidence: experimental; cloned [PMID:17604727,PMID:17616659],experimental; cloned [PMID:15978578,PMID:17604727,PMID:17616659], Northern [PMID:15978578]
miRBase link: https://www.mirbase.org/cgi-bin/mirna_entry.pl?acc=MI0000809
